# Mediators of Neuropathic Pain; Focus on Spinal Microglia, CSF-1, BDNF, CCL21, TNF-α, Wnt Ligands, and Interleukin 1β

**Authors:** Paul A. Boakye, Shao-Jun Tang, Peter A. Smith

PMC · DOI: 10.3389/fpain.2021.698157 · Frontiers in Pain Research · 2021-08-25

## TL;DR

This review explores how spinal microglia and various mediators contribute to neuropathic pain, highlighting differences between males and females.

## Contribution

The paper emphasizes the role of secondary and tertiary mediators in spinal microglia activation and their impact on pain transmission.

## Key findings

- Secondary mediators like CSF-1 and CCL21 activate spinal microglia, leading to the release of tertiary mediators such as BDNF and TNF-α.
- Tertiary mediators enhance excitatory transmission and reduce inhibitory transmission in the spinal dorsal horn, contributing to pain.
- Despite redundancy in mediators, blocking a single mediator can alleviate pain in experimental models, presenting a paradox.

## Abstract

Intractable neuropathic pain is a frequent consequence of nerve injury or disease. When peripheral nerves are injured, damaged axons undergo Wallerian degeneration. Schwann cells, mast cells, fibroblasts, keratinocytes and epithelial cells are activated leading to the generation of an “inflammatory soup” containing cytokines, chemokines and growth factors. These primary mediators sensitize sensory nerve endings, attract macrophages, neutrophils and lymphocytes, alter gene expression, promote post-translational modification of proteins, and alter ion channel function in primary afferent neurons. This leads to increased excitability and spontaneous activity and the generation of secondary mediators including colony stimulating factor 1 (CSF-1), chemokine C-C motif ligand 21 (CCL-21), Wnt3a, and Wnt5a. Release of these mediators from primary afferent neurons alters the properties of spinal microglial cells causing them to release tertiary mediators, in many situations via ATP-dependent mechanisms. Tertiary mediators such as BDNF, tumor necrosis factor α (TNF-α), interleukin 1β (IL-1β), and other Wnt ligands facilitate the generation and transmission of nociceptive information by increasing excitatory glutamatergic transmission and attenuating inhibitory GABA and glycinergic transmission in the spinal dorsal horn. This review focusses on activation of microglia by secondary mediators, release of tertiary mediators from microglia and a description of their actions in the spinal dorsal horn. Attention is drawn to the substantial differences in the precise roles of various mediators in males compared to females. At least 25 different mediators have been identified but the similarity of their actions at sensory nerve endings, in the dorsal root ganglia and in the spinal cord means there is considerable redundancy in the available mechanisms. Despite this, behavioral studies show that interruption of the actions of any single mediator can relieve signs of pain in experimental animals. We draw attention this paradox. It is difficult to explain how inactivation of one mediator can relieve pain when so many parallel pathways are available.

## Linked entities

- **Proteins:** CSF1 (colony stimulating factor 1), CCL21 (C-C motif chemokine ligand 21), WNT3A (Wnt family member 3A), WNT5A (Wnt family member 5A), BDNF (brain derived neurotrophic factor), TNF (tumor necrosis factor), IL1B (interleukin 1 beta)

## Full-text entities

- **Genes:** Ifngr1 (interferon gamma receptor 1) [NCBI Gene 15979] {aka CD119, IFN-gammaR, Ifgr, Ifngr, Nktar}, Prkcg (protein kinase C, gamma) [NCBI Gene 18752] {aka PKCgamma, Pkcc, Prkcc}, Il17a (interleukin 17A) [NCBI Gene 16171] {aka Ctla-8, Ctla8, IL-17, IL-17A, Il17}, SLC12A5 (solute carrier family 12 member 5) [NCBI Gene 57468] {aka DEE34, EIEE34, EIG14, KCC2, hKCC2}, CX3CL1 (C-X3-C motif chemokine ligand 1) [NCBI Gene 6376] {aka ABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT}, Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, EIF2AK3 (eukaryotic translation initiation factor 2 alpha kinase 3) [NCBI Gene 9451] {aka PEK, PERK, WRS}, Cck (cholecystokinin) [NCBI Gene 12424], Cx3cl1 (C-X3-C motif chemokine ligand 1) [NCBI Gene 20312] {aka ABCD-3, CX3C, Cxc3, D8Bwg0439e, FK, Scyd1}, Grin1 (glutamate ionotropic receptor NMDA type subunit 1) [NCBI Gene 24408] {aka GluN1, NMDAR1, NR1}, Slc12a5 (solute carrier family 12 member 5) [NCBI Gene 171373] {aka Kcc2}, Cxcl12 (C-X-C motif chemokine ligand 12) [NCBI Gene 20315] {aka Pbsf, Scyb12, Sdf1, Tlsf, Tpar1}, GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, ITIH4 (inter-alpha-trypsin inhibitor heavy chain 4) [NCBI Gene 3700] {aka GP120, H4P, IHRP, ITI-HC4, ITIHL1, PK-120}, P2rx7 (purinergic receptor P2X, ligand-gated ion channel, 7) [NCBI Gene 18439] {aka P2X(7), P2X7R}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, Csf1r (colony stimulating factor 1 receptor) [NCBI Gene 12978] {aka CD115, CSF-1R, Csfmr, Fim-2, Fim2, Fms}, Grin2b (glutamate ionotropic receptor NMDA type subunit 2B) [NCBI Gene 24410] {aka GluN2B}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Ctnnb1 (catenin beta 1) [NCBI Gene 84353] {aka Catnb}, Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 12912] {aka 2310001E10Rik, 3526402H21Rik, Creb, Creb-1}, P2ry12 (purinergic receptor P2Y12) [NCBI Gene 64803] {aka P2y12}, Ccr2 (C-C motif chemokine receptor 2) [NCBI Gene 12772] {aka Cc-ckr-2, Ccr2a, Ccr2b, Ckr2, Ckr2a, Ckr2b}, Calca (calcitonin-related polypeptide alpha) [NCBI Gene 24241] {aka CAL6, CGRP, CGRP1, Cal1, Calc, RATCAL6}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, P2rx1 (purinergic receptor P2X, ligand-gated ion channel, 1) [NCBI Gene 18436] {aka P2x, Pdcd3, RP-2}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Wnt5a (wingless-type MMTV integration site family, member 5A) [NCBI Gene 22418] {aka 8030457G12Rik, Wnt-5a}, Csf2 (colony stimulating factor 2 (granulocyte-macrophage)) [NCBI Gene 12981] {aka CSF, Csfgm, GMCSF, Gm-CSf, MGI-IGM}, Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 20296] {aka HC11, JE, MCAF, MCP-1, MCP1, SMC-CF}, Trpv1 (transient receptor potential cation channel, subfamily V, member 1) [NCBI Gene 193034] {aka OTRPC1, TRPV1alpha, TRPV1beta, VR-1, Vr1}, Wnt3a (wingless-type MMTV integration site family, member 3A) [NCBI Gene 22416] {aka Wnt-3a, vt}, WNT3A (Wnt family member 3A) [NCBI Gene 89780], P2ry14 (purinergic receptor P2Y, G-protein coupled, 14) [NCBI Gene 140795] {aka A330108O13Rik, Gpr105, P2Y14}, SCN10A (sodium voltage-gated channel alpha subunit 10) [NCBI Gene 6336] {aka FEPS2, Nav1.8, PN3, SNS}, AIF1 (allograft inflammatory factor 1) [NCBI Gene 199] {aka AIF-1, IBA1, IRT-1, IRT1}, Npy (neuropeptide Y) [NCBI Gene 109648] {aka 0710005A05Rik}, App (amyloid beta precursor protein) [NCBI Gene 54226] {aka Abeta}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, Wnt2 (Wnt family member 2) [NCBI Gene 114487] {aka Wnt}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, P2ry13 (purinergic receptor P2Y, G-protein coupled 13) [NCBI Gene 74191] {aka 2010001L06Rik, GPCR1, GPR94, Gpr86, P2Y13, P2yr13}, Gfap (glial fibrillary acidic protein) [NCBI Gene 14580], Pf4 (platelet factor 4) [NCBI Gene 56744] {aka Cxcl4, Scyb4}, Il15 (interleukin 15) [NCBI Gene 16168] {aka IL-15}, Fyn (FYN proto-oncogene, Src family tyrosine kinase) [NCBI Gene 25150], Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Ctss (cathepsin S) [NCBI Gene 13040] {aka Cats}, IL1R1 (interleukin 1 receptor type 1) [NCBI Gene 3554] {aka CD121A, CRMO3, D2S1473, IL-1R-alpha, IL-1RT1, IL1R}, Csf1 (colony stimulating factor 1 (macrophage)) [NCBI Gene 12977] {aka BAP025, Csfm, MCSF, Mhdabap25, PG-M-CSF, op}, Vti1b (vesicle transport through interaction with t-SNAREs 1B) [NCBI Gene 53612] {aka GES30, MVti1b, SNARE, Vti1-rp1}, LIF (LIF interleukin 6 family cytokine) [NCBI Gene 3976] {aka CDF, DIA, HILDA, MLPLI}, Trpm8 (transient receptor potential cation channel, subfamily M, member 8) [NCBI Gene 171382] {aka CMR1, LTRPC6, LTrpC-6, TRPP8, Trp-p8}, Ryk (receptor-like tyrosine kinase) [NCBI Gene 20187] {aka ERK-3, Vik}, Calca (calcitonin/calcitonin-related polypeptide, alpha) [NCBI Gene 12310] {aka CA, CGRP-1, CGRP1, Calc, Calc1, Cgrp}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Cx3cr1 (C-X3-C motif chemokine receptor 1) [NCBI Gene 13051] {aka mCX3CR1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, PLA2G1B (phospholipase A2 group IB) [NCBI Gene 5319] {aka PLA2, PLA2A, PPLA2}
- **Diseases:** fibromyalgia (MESH:D005356), painful HIV related neuropathy (MESH:D016263), chronic pain (MESH:D059350), complex regional pain syndrome (MESH:D020918), migraine (MESH:D008881), Inflammation (MESH:D007249), Inflammatory pain (MESH:D010146), cord (MESH:D013118), autoimmune disease (MESH:D001327), CCI (MESH:D020208), spinal cord injury (MESH:D013119), Wallerian Degeneration (MESH:D014855), rheumatoid arthritis (MESH:D001172), COVID-19 (MESH:D000086382), thermal and mechanical (MESH:D041781), autoimmune encephalomyelitis (MESH:D004681), diabetes (MESH:D003920), Peripheral nerve injury (MESH:D059348), neurogenic neuroinflammation (MESH:D020078), synaptic degeneration (MESH:D012183), nociceptive pain (MESH:D059226), nerve crush (MESH:D003444), traumatic brain injury (MESH:D000070642), allodynia (MESH:D006930), osteoarthritis (MESH:D010003), tissue injury (MESH:D017695), neuropathies (MESH:D009422), Peripheral nerve trauma (MESH:D010523), stroke (MESH:D020521), hypersensitivity (MESH:D004342), Nerve Injury (MESH:D000080902), thoracic disc herniation (MESH:D007405), Neuropathic pain (MESH:D009437), multiple sclerosis (MESH:D009103), toxicity (MESH:D064420), sciatic nerve after injury (MESH:D020426), neuroinflammation (MESH:D000090862), neuronal loss (MESH:D009410), HIV (MESH:D015658), Injuries (MESH:D014947), painful neuropathies (MESH:C564945), nerve injured (MESH:C537568)
- **Chemicals:** cilnidipine (MESH:C065927), NMDA (MESH:D016202), 5,6 EET (MESH:C040776), TTX (MESH:D013779), Chloride (MESH:D002712), lipopolysaccharide (MESH:D008070), GABA (MESH:D005680), APV (MESH:C095108), Cl- (MESH:D002713), Histamine (MESH:D006632), prostacyclin (MESH:D011464), MRS2578 (MESH:C541384), AMD3100 (MESH:C088327), K+ (MESH:D011188), carrageenan (MESH:D002351), Na+ (MESH:D012964), A-803467 (MESH:C520740), MRS2211 (MESH:C556691), NBI-74330 (MESH:C501976), NO (MESH:D009614), bupivacaine (MESH:D002045), calcium (MESH:D002118), ATP (MESH:D000255), prostaglandin E2 (MESH:D015232), Ca2+ (-), minocycline (MESH:D008911), eicosanoid (MESH:D015777), ceramide (MESH:D002518), arachidonic acid (MESH:D016718), formalin (MESH:D005557), Prostaglandins (MESH:D011453), glutamate (MESH:D018698), paclitaxel (MESH:D017239)
- **Species:** Toxoplasma gondii (species) [taxon 5811], Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus 1 (no rank) [taxon 11676], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC8915739/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC8915739/full.md

## References

462 references — full list in the complete paper: https://tomesphere.com/paper/PMC8915739/full.md

---
Source: https://tomesphere.com/paper/PMC8915739